secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lipocine Inc. (LPCN)
CIK:        0001535955
Form:       8-K
Filed at:   2024-04-26T23:59:59+00:00
Accession:  0001493152-24-016777
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 1.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lipocine enters new $10.6M ATM sales agreement with A.G.P., terminates prior Cantor facility
--------------------------------------------------------------------------------

- Entered ATM agreement with A.G.P./Alliance Global Partners to sell up to $10,616,169 of common stock at market prices.
- A.G.P. will receive 3.0% of aggregate gross proceeds from each sale under the agreement.
- Terminated prior ATM agreement with Cantor Fitzgerald & Co., effective immediately, to enter new facility.
- Either party may terminate the new agreement upon ten days' prior notice; no obligation to sell shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1535955/000149315224016777/0001493152-24-016777-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1535955/000149315224016777/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-016777

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer